OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
28/05/2026
Voltar para busca
Dado oficial do USPTO
HAEMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
29/05/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35, 42, 44
Data de depósito
04/07/2024
Data de registro
26/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/08/2025
Última transação
29/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
DE
Examinador
CORWIN, KEVIN SCOTT
Unidade examinadora
M30
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the red stylized wording "HAEMA"; to the right of the wording "HAEMA" appears a red circle, beneath which appears a red band curved upward at each end.
Titulares e representantes
Titulares
Haema GmbH
Haema AG
Representantes
Deborah L. Shapiro Moses & Singer LLP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicinesin particular medicines made from blood componentsfractions and preparationswith said medicines being for the treatment of diseases and disorders of the blood; Blood componentsfractions and preparationsblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for injectionblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for automatic transplantationblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for transfusionblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for immunotherapyblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for autologous transfusionblood for medical purposesblood plasmablood substitutes for human use; Bloodblood fractions and blood components for medicaltherapeuticprophylactic purposesblood for medical purposesblood plasmablood substitutes for human use; Blood plasma; Cells for medical useblood cell preparations; Health care substances and preparationsin particular for haematologypharmaceuticals for the treatment of blood diseases and disordersblood for medical purposesblood plasmablood substitutes for human use; Finished medical productsblood for human use and blood plasma; Preparations for medical purposesin particular haematology preparations namelypharmaceuticals for the treatment of blood diseases and disordersblood for medical purposesblood plasmablood substitutes for human use; Immunotherapeutic and immunoprophylactic preparationspharmaceuticals for treating immunological diseases and disorders; Living cells for medical purposesleukocyte preparations of white blood cells; Living cells and cell fragments for medical purposesplatelet and red blood cell concentrates; Blood plasmaquarantine plasma and fractionated plasma; Clinical medical reagents for processing human blood and blood components for use in blood transfusions and for extracorporeal blood processing stored in bagsbottlessyringes and similar containers for storing substances such as these for medical purposes; Pharmaceutical products and haematology preparations including those for the treatment of blood and blood componentsin particular infusion and transfusion solutions in the nature of bloodblood plasmablood substitutes for human use and pharmaceuticals for the treatment of blood diseases and disorders; Pharmaceutical blood plasma preparations for the treatment of blood diseasesblood disorders; Pharmaceutical blood preparations for the treatment of blood diseasesblood disorders; Pharmaceutical blood productspharmaceuticals for the treatment of blood diseasesblood disorders; Cell material for autotransplantation and autotransfusioncells for medical use; Cell material for transplantation and transfusioncells for medical use; Cell material for medicaltherapeutic and prophylactic purposescells for medical purposes
Classe 35
Maintenance of blood donor data in computer databases
Classe 42
Technical provision and support for data processing systemsproviding technology information in the field of data processing and technical support services in the nature of troubleshooting computer software problems in connection with data processing; Providing temporary use of onlinenon-downloadable software for accessing patient treatment databases and donor databases; Providing technological and scientific information about scientific laboratory services and blood banksin particular medical research laboratories; Providing of scientific information derived from analysis of medical diagnostic results; Blood analysis services for scientific research purposes; Scientific laboratory services; Chemical laboratories and medical research laboratories; Scientific research in the field of physics; Chemistry serviceschemical analysischemical laboratories; Chemical analysis; Scientific testing servicesblood testing for scientific research purpose; Blood testing for scientific research purposeswith said testing entailing the filtrationseparation and centrifugation of blood; Laboratory trialsmedical and scientific research in the nature of conducting clinical trials for others; Development and further development of data processing computer software and hardware in the field of laboratory medicine and blood and plasma collection; Database development servicescreation of medical databases in digital form; Scientific and medical research in the medical and pharmaceutical fields; Scientific and medical research in the field of chemistry and biology; Development and establishment of testing specifications and procedures for the medical industrydevelopment of medical equipment procedures and test proceduresdonation proceduresmedical instrument procedures; Data processing servicestechnical and scientific registration and processing of patient treatment data and donor data in databases; Scientific laboratory services
Classe 44
Medical analysis services for diagnostic and treatment purposes provided by medical laboratories in connection with blood and plasma donation and clinical medical consultations in connection with the same; Clinical medical consultation services in relation to transfusion medicine; pharmacy advice; Providing of medical information in relation to blood donation centres; Providing of medical and pharmaceutical support via telephoneproviding medical information generally; Medical services featuring blood fractionation or treatment; Medical services in the nature of blood sampling and collection; blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Pharmacy servicespreparation of prescriptions in pharmacies; Medical assistance; Blood bank services; Blood bank services in the nature of blood donation centres; Blood bank services in the nature of blood extraction stations; Services in the field of immunotherapymedical care; Consulting services in the field of medical careconsultancy in relation to transfusion medicine and clinic hygienemedical transfusion consultancy in clinicsin particular consultancy by doctors administering transfusionsmedical transfusion testing; Medical careimmunotherapy; Providing medical informationmedical diagnostic information through medical results; Medical careconducting medical diagnostics within the framework of conducting medical examinations; Blood bank servicescollecting of blood donationsincluding platelet donationsSDR donation being erythrocyte donationwhole blood donationplasma donationautologous donation being multiple types of cellular donations from an individual; Medical careexecution of medical and clinical examination services; Dietetic advisory services; Providing medical opinions in the nature of medical advice in the field of weight lossdermatologyhematology; Health counselling; Medical caretransfusion or transplantation of blood and blood components; Medical services; Medical carethe use of medical equipmentinstruments and apparatus for medical care purposes; Blood bank servicesservices of packed red blood cell banks; Blood bank servicesservices of platelet concentrate banks; Blood bank servicesservices of leukocyte banks; Blood bank servicesservices of blood plasma banks and collection and preservation of blood for medical and diagnostic purposes; Blood bank servicesblood component banks; Medical servicesextraction of stem cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/05/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/05/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/05/2026
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
15/03/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
15/03/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/08/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
26/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/07/2025
PUBO
PUBLISHED FOR OPPOSITION
08/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/06/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
18/04/2025
RFNT
REFUSAL PROCESSED BY IB
15/02/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/01/2025
RFRR
REFUSAL PROCESSED BY MPU
27/01/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/12/2024
CNRT
NON-FINAL ACTION WRITTEN
26/12/2024
DOCK
ASSIGNED TO EXAMINER
21/12/2024
MAFR
APPLICATION FILING RECEIPT MAILED
12/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/12/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/12/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HAEMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.